IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Doxorubicin and etoposide are clinically effective antitumor agents.
• Both drugs target topoisomerase II, inducing DNA cleavage and double-strand breaks, leading to tumor cell death.
• Extensive metabolism of these drugs generates reactive intermediates and free radicals, causing DNA and protein damage.

Purpose of the Study:

• To critically evaluate the significance of metabolic activation in the mechanism of tumor cytotoxicity for doxorubicin and etoposide.
• To elucidate the role of drug activation in the overall cytotoxic effect of these antitumor agents.

Main Methods:

• Literature review of existing research on doxorubicin and etoposide.
• Critical analysis of studies investigating drug metabolism and cytotoxicity.
• Evaluation of the role of reactive intermediates and free radical formation.

Main Results:

• Doxorubicin and etoposide are known to cause DNA damage via topoisomerase II inhibition.
• Metabolic activation produces reactive intermediates that bind to DNA and proteins.
• Free radical generation contributes to lipid peroxidation and DNA damage.

Conclusions:

• The precise role of metabolic activation in the cytotoxicity of doxorubicin and etoposide remains incompletely defined.
• Further research is needed to fully understand how drug activation contributes to tumor cell death.
• Clarifying this mechanism could lead to improved cancer treatment strategies.